Rosuzet 5 Mg/10 Mg, Rosuzet 10 Mg/10 Mg, Rosuzet 20 Mg/10 Mg, Rosuzet 40 Mg/10 Mg 5 mg, 10 mg, 20 mg, 40 mg Tablet
PDF Leaflet Revision Date: TBA
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive therapy for primary hypercholesterolemia and cardiovascular event prevention.
Dosage (summary)
One tablet daily; starting dose 10 mg rosuvastatin + 10 mg ezetimibe.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; use effective contraception.
Key Drug Interactions
- Gemfibrozil
- Ciclosporin
- Protease inhibitors
Contraindications
- Hypersensitivity
- Active liver disease
- Severe renal impairment
- Pregnancy and breastfeeding
Common side effects
- Myalgia
- Headache
- Dizziness
- Nausea
Counselling Points
- Report unexplained muscle pain or weakness.
- Monitor liver function tests.
- Maintain a lipid-lowering diet.
Serious warnings
- Risk of myopathy/rhabdomyolysis
- Liver function monitoring required
- Diabetes risk
Important Disclaimer
The Rosuzet 5 Mg/10 Mg, Rosuzet 10 Mg/10 Mg, Rosuzet 20 Mg/10 Mg, Rosuzet 40 Mg/10 Mg 5 mg, 10 mg, 20 mg, 40 mg Tablet professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
